Abstract
Low-dose oral sirolimus appears to increase the risk of menstrual-cycle disturbances and ovarian cysts. Monitoring patients for sirolimus-associated ovarian toxicity may be considered.
Cite
CITATION STYLE
APA
Braun, M., Young, J., Reiner, C. S., Poster, D., Wüthrich, R. P., & Serra, A. L. (2012). Ovarian Toxicity from Sirolimus. New England Journal of Medicine, 366(11), 1062–1064. https://doi.org/10.1056/nejmc1113145
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free